Evidence map›Paper›PMID 35882956›Full record

ArticleCommunications biology2022

TRPM7 deficiency exacerbates cardiovascular and renal damage induced by aldosterone-salt.

Francisco J Rios, Zhi-Guo Zou, Adam P Harvey, Katie Y Harvey, Livia L Camargo, Karla B Neves, Sarah E F Nichol, Rheure Alves-Lopes, Alexius Cheah, Maram Zahraa and 6 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Reactive oxygen species in hypertension.Nature reviews. Cardiology · 2025
    Review
  10. TRPM channels in health and disease.Nature reviews. Nephrology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 4 countries.

Francisco J RiosInstitute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK. Francisco.Rios@glasgow.ac.uk.ORCID 0000-0002-8194-0787
Zhi-Guo ZouInstitute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Adam P HarveyInstitute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.ORCID 0000-0002-2845-4982
Katie Y HarveyInstitute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Livia L CamargoInstitute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.ORCID 0000-0002-7451-7147
Karla B NevesInstitute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.ORCID 0000-0001-5158-9263
Sarah E F NicholInstitute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.ORCID 0000-0002-6976-3714
Rheure Alves-LopesInstitute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Alexius CheahInstitute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Maram ZahraaInstitute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Alexey G RyazanovDepartment of Pharmacology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Lillia RyazanovaLewis Sigler Institute of Integrative Genomics, Princeton University, Princeton, NJ, USA.
Thomas GudermannWalther-Straub Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität München, Munich, Germany.ORCID 0000-0002-0323-7965
Vladimir ChubanovWalther-Straub Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität München, Munich, Germany.ORCID 0000-0002-6042-4193
Augusto C MontezanoInstitute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Rhian M TouyzInstitute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK. rhian.touyz@mcgill.ca.ORCID 0000-0003-0670-0887
University of Glasgow · GBLudwig-Maximilians-Universität München · DEMcGill University Health Centre · CAPrinceton University · USRutgers, The State University of New Jersey · US

Funding

British Heart Foundation CH/12/4/29762British Heart Foundation RE/18/6/34217
6 · The paper itself

Abstract

Hyperaldosteronism causes cardiovascular disease as well as hypomagnesemia. Mechanisms are ill-defined but dysregulation of TRPM7, a Mg

Indexed as

HyperaldosteronismTRPM Cation ChannelsAldosteroneAnimalsFibrosisKidneyMagnesiumMiceProtein Phosphatase 2CSodium ChlorideAldosteroneMagnesiumPpm1a protein, mouseProtein Phosphatase 2CSodium ChlorideTrpm7 protein, mouseTRPM Cation Channels

Identifiers

PMID35882956
PMCPMC9325869
OpenAlexW4287958437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.